Pharmaceutical

AstraZeneca’s STRIDE shows improved outcomes for liver cancer patients

AstraZeneca has announced impressive results for its STRIDE regimen, significantly boosting survival rates for advanced HCC patients.

Jun 29, 2023 - 20:00
AstraZeneca’s STRIDE shows improved outcomes for liver cancer patients
AstraZeneca has announced impressive results for its STRIDE regimen, significantly boosting survival rates for advanced HCC patients.
Read the original article

Tags:

Previous Article

FDA rejects Alvotech’s Humira biosimilar for the third time

Next Article

Lantidra wins FDA approval as first-ever type 1 diabetes cell therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Medtronic isn’t afraid of Wegovy’s potential to disrupt

Medtronic isn’t afraid of Wegovy’s potential to disrupt

Nov 23, 2023

STAT+: Supreme Court pauses new limits on abortion pill, pending further review next week

STAT+: Supreme Court pauses new limits on abortion pill...

Apr 17, 2023

STAT+: Biogen board and C-suite are in step as they eye M&A opportunities, new CEO says

STAT+: Biogen board and C-suite are in step as they eye...

Jun 6, 2023